A detailed history of Artisan Partners Limited Partnership transactions in Dexcom Inc stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 1,652,384 shares of DXCM stock, worth $133 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,652,384
Previous 5,627,790 70.64%
Holding current value
$133 Million
Previous $638 Million 82.64%
% of portfolio
0.17%
Previous 1.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $254 Million - $461 Million
-3,975,406 Reduced 70.64%
1,652,384 $111 Million
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $15.6 Million - $19.8 Million
-141,329 Reduced 2.45%
5,627,790 $638 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $15 Million - $18.4 Million
-131,189 Reduced 2.22%
5,769,119 $800 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $277 Million - $456 Million
3,672,471 Added 164.84%
5,900,308 $732 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $17.1 Million - $27.4 Million
-198,548 Reduced 8.18%
2,227,837 $208 Million
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $49.1 Million - $57.2 Million
436,852 Added 21.96%
2,426,385 $312 Million
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $28.9 Million - $34.2 Million
-278,015 Reduced 12.26%
1,989,533 $231 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $61 Million - $88 Million
717,251 Added 46.27%
2,267,548 $257 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $62,454 - $77,039
-818 Reduced 0.05%
1,550,297 $125 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $74.7 Million - $146 Million
1,098,144 Added 242.43%
1,551,115 $116 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $56.1 Million - $77.6 Million
-595,958 Reduced 56.82%
452,971 $232 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $94.2 Million - $118 Million
-725,470 Reduced 40.89%
1,048,929 $563 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $21.3 Million - $28.6 Million
-199,620 Reduced 10.11%
1,774,399 $970 Million
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $501,328 - $668,086
6,190 Added 0.31%
1,974,019 $843 Million
Q1 2021

May 11, 2021

BUY
$84.79 - $104.74 $38.3 Million - $47.3 Million
451,362 Added 29.76%
1,967,829 $707 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $31.7 Million - $42.4 Million
406,191 Added 36.58%
1,516,467 $561 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $2.97 Million - $3.51 Million
-31,116 Reduced 2.73%
1,110,276 $458 Million
Q2 2020

Aug 12, 2020

SELL
$62.68 - $105.34 $28.1 Million - $47.2 Million
-448,310 Reduced 28.2%
1,141,392 $463 Million
Q1 2020

May 12, 2020

SELL
$47.79 - $75.63 $14.2 Million - $22.4 Million
-296,114 Reduced 15.7%
1,589,702 $428 Million
Q4 2019

Feb 12, 2020

SELL
$36.62 - $57.29 $3.7 Million - $5.79 Million
-101,118 Reduced 5.09%
1,885,816 $413 Million
Q3 2019

Nov 12, 2019

BUY
$35.53 - $43.8 $3.63 Million - $4.48 Million
102,218 Added 5.42%
1,986,934 $297 Million
Q2 2019

Aug 09, 2019

BUY
$27.84 - $38.92 $20.1 Million - $28 Million
720,635 Added 61.91%
1,884,716 $282 Million
Q1 2019

May 10, 2019

BUY
$28.07 - $38.18 $13.6 Million - $18.5 Million
485,519 Added 71.55%
1,164,081 $139 Million
Q4 2018

Feb 12, 2019

SELL
$26.99 - $37.37 $938,469 - $1.3 Million
-34,771 Reduced 4.87%
678,562 $81.3 Million
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $1.11 Million - $1.75 Million
47,750 Added 7.17%
713,333 $102 Million
Q2 2018

Aug 10, 2018

BUY
$17.54 - $25.22 $21,819 - $31,373
1,244 Added 0.19%
665,583 $63.2 Million
Q1 2018

May 10, 2018

SELL
$13.06 - $18.54 $17.1 Million - $24.3 Million
-1,312,059 Reduced 66.39%
664,339 $49.3 Million
Q4 2017

Feb 12, 2018

SELL
$11.12 - $15.38 $18.3 Million - $25.3 Million
-1,645,984 Reduced 45.44%
1,976,398 $113 Million
Q3 2017

Nov 13, 2017

BUY
$11.36 - $18.98 $41.2 Million - $68.8 Million
3,622,382
3,622,382 $177 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.